2013 Summit Speakers - Biographies

Thursday, September 19, 2013 - Summit Opening

Summit Introduction and Overview:

Mr. Thomas A. Farrington


PHEN Consensus Statement for PSA Testing for African American  and Other High Risk Men

A History of the PSA Test - Why the Controversy?
Thomas W. Jarrett, M.D.

Presenting the PHEN Consensus Statement
Mr. Thomas A. Farrington

Consensus Statement Comments and Analysis
Compton Benjamin, M.D., Ph.D.

New Devolopments and Evolving Trends - Part I


The Importance of African American Participation in Clinical Trials
Sara Horton, M.D.

The Provenge Enrollment Experience

Robert C. Tyler, Ph.D.

What is Sterotactic Body Radiation Therapy and its Advantages?
Sean P. Collins, M.D., Ph.D.

A Novel Approach to Funding Research Efforts
Channing Judith Paller, M.D., Ph.D. 
Joel Nowak, M.S.W.

Educating Black America About Prostate Cancer

Friday, September 20, 2013

Opening Remarks:

Mr. Thomas A. Farrington

Active Surveillance-To Treat or Not to Treat Prostate Cancer


The Evidence Supporting Active Surveillance
H. Bellentine Carter, M.D.

Active Surveillance and African Americans; A Study's Findings
Edward M. Schaeffer, M.D., Ph.D.

Prognostic Tests to Help Determine if the Cancer is Life-Threatening
Béla S. Denes, M.D., F.A.C.S.
Michael Brawer, M.D.
New Developments and Evolving Trends - Part II


Mr. Harry Bass

An Update on the ProstVac Immunotherapy Clinical Trial
Jennifer Harris, Pharm.D.

The DOD Prostate Cancer Research Program Update

Carolyn J.M. Best. Ph.D.

The Stand Up to Cancer Prostate Cancer Dream Team Project
Mr. Mark Kennedy

Summit Closing Remarks:

Mr. Thomas A. Farrington

PHEN,Inc. © 2018 All rights reserved